1
|
Li Q, Zhou HB, Liu JQ, Bai WF, Wang J, Yang ZJ, Qiu M, Chang H, Shi SL. The intervention effect of Amygdalus mongolica oil on the metabolomics and intestinal flora in pulmonary fibrosis. Front Pharmacol 2022; 13:1037563. [PMID: 36386194 PMCID: PMC9663812 DOI: 10.3389/fphar.2022.1037563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Accepted: 10/14/2022] [Indexed: 11/28/2022] Open
Abstract
Amygdalus mongolica oil is rich in unsaturated fatty acids such as inoleic acid (47.11%) and oleic acid (23.81%). Our research demonstrates that it exerts a protective effect on rat models of pulmonary fibrosis, however, little is known regarding the underlying mechanism of action. This study aimed to characterize the therapeutic mechanism of action of A. mongolica oil on bleomycin-induced pulmonary fibrosis in rats. A. mongolica oil appears to regulate the levels of potential key serum biomarkers which include tetrahydrobiopterin, L-serine, citrulline and estradiol to participate in folate biosynthesis, glycine, serine and threonine metabolism, arginine biosynthesis and steroid hormone biosynthesis. And it also enriched intestinal microbial abundance, homogeneity and modulated the abundance of Duncaniell, Desulfovibrio, Peptococcaceae_unclassified, Dubosiella, Tyzzerella, Lachnospiraceae_NK4A136_group, Lactobacillus, Clostridiales_unclassified to exert a protective effect against pulmonary fibrosis. A. mongolica oil appears to confer protective effects against pulmonary fibrosis by affecting the level of pulmonary fibrosis metabolites and the abundance of related intestinal flora through multiple targets, as evidenced by our untargeted LC-MS/MS metabonomics evaluation and 16S rDNA sequencing technology.
Collapse
Affiliation(s)
- Qian Li
- 1Department of Pharmacy, Baotou Medical College, Baotou, China,2Inner Mongolia Maternal and Child Health Care Hospital, Hohhot, China
| | - Hong-Bing Zhou
- 1Department of Pharmacy, Baotou Medical College, Baotou, China,3Institute of Bioactive Substance and Function of Mongolian Medicine and Chinese Materia Medica, Baotou Medical College, Baotou, China
| | - Jia-Qi Liu
- 1Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Wan-Fu Bai
- 1Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Jia Wang
- 1Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Zhan-Jun Yang
- 3Institute of Bioactive Substance and Function of Mongolian Medicine and Chinese Materia Medica, Baotou Medical College, Baotou, China
| | - Min Qiu
- 1Department of Pharmacy, Baotou Medical College, Baotou, China,3Institute of Bioactive Substance and Function of Mongolian Medicine and Chinese Materia Medica, Baotou Medical College, Baotou, China
| | - Hong Chang
- 1Department of Pharmacy, Baotou Medical College, Baotou, China,*Correspondence: Hong Chang, ; Song-Li Shi,
| | - Song-Li Shi
- 1Department of Pharmacy, Baotou Medical College, Baotou, China,3Institute of Bioactive Substance and Function of Mongolian Medicine and Chinese Materia Medica, Baotou Medical College, Baotou, China,*Correspondence: Hong Chang, ; Song-Li Shi,
| |
Collapse
|
2
|
Gao C, Chang H, Zhou HB, Liu Q, Bai YC, Liu QL, Bai WF, Shi SL. Metabolomics reveal the mechanism for anti-renal fibrosis effects of an n-butanol extract from Amygdalus mongolica. Acta Pharm 2022; 72:437-48. [PMID: 36651545 DOI: 10.2478/acph-2022-0023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 09/14/2021] [Indexed: 01/26/2023]
Abstract
To reveal the mechanism of anti-renal fibrosis effects of an n-butanol extract from Amygdalus mongolica, renal fibrosis was induced with unilateral ureteral obstruction (UUO) and then treated with an n-butanol extract (BUT) from Amygdalus mongolica (Rosaceae). Sixty male Sprague-Dawley rats were randomly divided into the sham-operated, renal fibrosis (RF) model, benazepril hydrochloride-treated model (1.5 mg kg-1) and BUT-treated (1.75, 1.5 and 1.25 g kg-1) groups and the respective drugs were administered intragastrically for 21 days. Related biochemical indices in rat serum were determined and histopathological morphology observed. Serum metabolomics was assessed with HPLC-Q-TOF-MS. The BUT reduced levels of blood urea nitrogen, serum creatinine and albumin and lowered the content of malondialdehyde and hydroxyproline in tissues. The activity of superoxide dismutase in tissues was increased and an improvement in the severity of RF was observed. Sixteen possible biomarkers were identified by metabolomic analysis and six key metabolic pathways, including the TCA cycle and tyrosine metabolism, were analyzed. After treatment with the extract, 8, 12 and 9 possible biomarkers could be detected in the high-, medium- and low-dose groups, respectively. Key biomarkers of RF, identified using metabolomics, were most affected by the medium dose. A. mongolica BUT extract displays a protective effect on RF in rats and should be investigated as a candidate drug for the treatment of the disease.
Collapse
|
3
|
Zhang L, Sun F, Ma S, Wang C, Wei B, Zhang Y. Phylogeography of Amygdalus mongolica in relation to Quaternary climatic aridification and oscillations in northwestern China. PeerJ 2022; 10:e13345. [PMID: 35509965 PMCID: PMC9059755 DOI: 10.7717/peerj.13345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Accepted: 04/06/2022] [Indexed: 01/14/2023] Open
Abstract
Quaternary period geological events and climatic oscillations significantly affect the geographic structure and genetic diversity of species distribution in arid northwestern China. Amygdalus mongolica is a relict and endangered shrub that occurs primarily in arid areas of northwestern China. Based on variation patterns present at three cpDNA regions (psbK-psbI, trnL-trnF and trnV) and in one nDNA sequence (ITS1-ITS4) in 174 individuals representing 15 populations, the spatial genetic structure and demographic history of A. mongolica was examined across its entire geographic range. The 17 different haplotypes and 10 ribotypes showed two lineages, distributed across the Western (Mazong Mountains, Hexi Corridor, and Alxa Left Banner) and Eastern regions (Urad Houqi, Yinshan Mountains, Urad Zhongqi, and Daqing Mountains) according to the median-joining network and the BI (Bayesian inference) and ML (Maximum likelihood) trees. AMOVA analysis demonstrated that over 65% of the observed genetic variation was related to this lineage split. The expansions of the Ulanbuhe and Tengger deserts and the eastward extension of the Yinshan Mountains since the Quaternary period likely interrupted gene flow and triggered the observed divergence in the two allopatric regions; arid landscape fragmentation accompanied by local environmental heterogeneity further increased local adaptive differentiation between the Western and Eastern groups. Based on the evidence from phylogeographical patterns and the distribution of genetic variation, A. mongolica distributed in the eastern and western regions are speculated to have experienced eastward migration along the southern slopes of the Lang Mountains and westward migration along the margins of the Ulanbuhe and Tengger deserts to the Hexi Corridor, respectively. For setting a conservation management plan, it is recommended that the south slopes of the Lang Mountains and northern Helan Mountains be identified as the two primary conservation areas, as they have high genetic variation and habitats that are more suitable.
Collapse
Affiliation(s)
- Lin Zhang
- Shihezi University, Xinjiang Production and Construction Corps Key Laboratory of Oasis Town and Mountain-basin System Ecology, College of Science, Shihezi, Xinjiang, China
| | - Fangfang Sun
- Shihezi University, Xinjiang Production and Construction Corps Key Laboratory of Oasis Town and Mountain-basin System Ecology, College of Science, Shihezi, Xinjiang, China
| | - Songmei Ma
- Shihezi University, Xinjiang Production and Construction Corps Key Laboratory of Oasis Town and Mountain-basin System Ecology, College of Science, Shihezi, Xinjiang, China
| | - Chuncheng Wang
- Shihezi University, Xinjiang Production and Construction Corps Key Laboratory of Oasis Town and Mountain-basin System Ecology, College of Life Sciences, Shihezi, Xinjiang, China
| | - Bo Wei
- Institute of Geographic Sciences and Natural Resources Research, Beijing, China
| | - Yunling Zhang
- General grassland station of Xinjiang, Urumqi, Xingjiang, China
| |
Collapse
|
4
|
Wang J, Zhou H, Wu T, Wu P, Liu Q, Shi S. Amygdalin isolated from Amygdalus mongolica protects against hepatic fibrosis in rats. Acta Pharm 2021; 71:459-71. [PMID: 36654093 DOI: 10.2478/acph-2021-0022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 07/21/2020] [Indexed: 01/20/2023]
Abstract
The aim of this research was to investigate the effect of amygdalin on hepatic fibrosis in rats. Amygdalin was purified and identified from the seeds of Amygdalus mongo lica. Sprague Dawley rats in the control and model groups were administered water. Sprague Dawley rats were divided into the low-, middle-, and high-dose amygdalin groups that received 20, 40, and 80 mg kg-1 amygdalin, respectively. whereas the silymarin group was treated with 50 mg kg-1 silymarin. The control and model groups were administered water. Liver tissue analysis revealed significantly lower activities of ALT, AST, ALP, SOD, and MDA in the drug-treated groups compared to the model group. Serum analysis revealed significantly lower HYC and C-IV in the middle-dose amygdalin-treated group compared to the model group. The histopathological changes were less severe in the drug-treated groups as observed by the formation of pseudolobuli and decreased collagen fiber deposition. Hepatic fibrosis-related genes were expressed at significantly lower levels in the amygdalin-treated groups than in the model group. Amygdalin from A. mongolica represents a therapeutic candidate for hepatic fibrosis prevention and treatment.
Collapse
|
5
|
Bai W, Liu Q, Chang H, Liu Q, Gao C, Bai Y, Zhou H, Shi S. Metabolomics reveals the renoprotective effect of n-butanol extract and amygdalin extract from Amygdalus mongolica in rats with renal fibrosis. Artif Cells Nanomed Biotechnol 2021; 49:556-564. [PMID: 34278886 DOI: 10.1080/21691401.2021.1952212] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Renal fibrosis (RF) is a pathological process of progression from chronic kidney disease to end-stage renal disease. Amygdalus mongolica is a traditional Chinese medicine, and our previous studies demonstrated that the n-butanol extract (BUT) and amygdalin extract (AMY) from its seeds can prevent RF. However, the underlying mechanism remains unclear. The present study investigated the exact mechanism of the protective effect of A. mongolica on RF. A renal fibrosis rat model was induced with unilateral ureteral obstruction. Biochemical indicators were measured and combined with histopathology of renal tissue to evaluate the anti-RF effects. A serum metabonomic method was used to clarify the changes in the metabolic profile. The tubulointerstitial damage and fibrosis were significantly improved and metabolic perturbations were restored after treatment with BUT and AMY. Thirty-eight metabolites associated with RF progression and related to the regulation of arginine and proline metabolism, nicotinate and nicotinamide metabolism, and histidine metabolism were identified. They were restored to levels similar to those in controls after treatment. Moreover, no significant differences in efficacy were observed between the BUT and AMY groups. This study reveals and compares the potential mechanisms of the renoprotective effects after treatment with BUT and AMY from a metabolomic perspective.
Collapse
Affiliation(s)
- Wanfu Bai
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Qing Liu
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Hong Chang
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Quanli Liu
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Chen Gao
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Yingchun Bai
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Hongbing Zhou
- Department of Pharmacy, Baotou Medical College, Baotou, China
| | - Songli Shi
- Department of Pharmacy, Baotou Medical College, Baotou, China
| |
Collapse
|
6
|
Chang H, Liu Q, Bai WF, Bai YC, Jia XY, Gao C, Liu QL, Shi SL, Zhou HB. Protective effects of Amygdalus mongolica on rats with renal fibrosis based on serum metabolomics. J Ethnopharmacol 2020; 257:112858. [PMID: 32278030 DOI: 10.1016/j.jep.2020.112858] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 03/26/2020] [Accepted: 04/06/2020] [Indexed: 06/11/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Renal fibrosis (RF) is a common outcome of various progressive chronic kidney diseases (CKDs) and, thus, seriously endangers human health. As the active ingredient of Amygdalus mongolica, amygdalin inhibits RF. Furthermore, our previous studies demonstrated that n-butanol extract (BUT) and petroleum ether extract (PET), which are effective components of A. mongolica, have an anti-renal fibrosis effect. However, their potential mechanisms of action are unclear and need further verification. AIMS OF THE STUDY The aims of this study were to further investigate the effects and potential mechanisms of A. mongolica extracts in the treatment of RF. MATERIALS AND METHODS The animals were divided into the control group, RF model group, PET group and BUT group. The RF rat model was established through unilateral ureteral obstruction (UUO). Biochemical indicators, including blood urea nitrogen (BUN), serum creatinine (Scr), and hydroxyproline (HYP, a routine marker of fibrosis), and the antioxidant index (including superoxide dismutase (SOD) and malondialdehyde (MDA)) were measured to evaluate the anti-RF effects of the extracts of A. mongolica. The histomorphology of renal tissue was observed and scored by HE and Masson staining. A serum metabonomic analysis based on UPLC-Q-TOF/MS was performed to assess the changes in the metabolic profile among the different groups. RESULTS The results showed that PET and BUT significantly improved tubulointerstitial damage and fibrosis by reducing the levels of Scr, BUN, HYP, and MDA and increasing the level of SOD. Moreover, no significant differences in efficacy were observed between the BUT and PET groups. According to the metabolomics analysis, seventy-four potential biomarkers were identified, and eight crucial biomarkers were further selected. These key biomarkers significantly contributed to RF progression by participating in six metabolic pathways, including pathways involved in arginine and proline metabolism, histidine metabolism, nicotinamide metabolism, pentose and glucuronate interconversion, ascorbate and aldarate metabolism, and amino sugar and nucleotide sugar metabolism. In addition, eight key biomarkers and six crucial biomarkers were restored to levels similar to those observed in controls following the treatment with PET and BUT, respectively. CONCLUSIONS The outcomes of these studies demonstrate the renoprotective effects of A. mongolica extracts in rats with RF and revealed the mechanism underlying these antifibrotic effects on metabolic activity for the first time.
Collapse
Affiliation(s)
- Hong Chang
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Qing Liu
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Wan-Fu Bai
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Ying-Chun Bai
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Xiao-Ye Jia
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Chen Gao
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Quan-Li Liu
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China; Academician Work Station for Efficacy, Pharmacology and Safety Evaluation of Mongolian Medicine, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Song-Li Shi
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China; Academician Work Station for Efficacy, Pharmacology and Safety Evaluation of Mongolian Medicine, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| | - Hong-Bing Zhou
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China.
| |
Collapse
|